OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cell cycle involvement in cancer therapy; WEE1 kinase, a potential target as therapeutic strategy
Sajjad Vakili‐Samiani, Omid Joodi Khanghah, Elham Gholipour, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2022) Vol. 824, pp. 111776-111776
Closed Access | Times Cited: 22
Sajjad Vakili‐Samiani, Omid Joodi Khanghah, Elham Gholipour, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2022) Vol. 824, pp. 111776-111776
Closed Access | Times Cited: 22
Showing 22 citing articles:
Potential of Copper and Copper Compounds for Anticancer Applications
Peng Ji, Peng Wang, Hao Chen, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 234-234
Open Access | Times Cited: 84
Peng Ji, Peng Wang, Hao Chen, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 234-234
Open Access | Times Cited: 84
New Horizons in Lung Cancer Management Through ATR/CHK1 Pathway Modulation
Riya Thapa, Obaid Afzal, Asif Ahmad Bhat, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 19, pp. 1807-1818
Open Access | Times Cited: 47
Riya Thapa, Obaid Afzal, Asif Ahmad Bhat, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 19, pp. 1807-1818
Open Access | Times Cited: 47
Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review
Sara Abdolmaleki, Alireza Aliabadi, Samad Khaksar
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 23
Sara Abdolmaleki, Alireza Aliabadi, Samad Khaksar
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 23
Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer
Siyao Deng, Tijana Vlatkovic, Moying Li, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4874-4874
Open Access | Times Cited: 29
Siyao Deng, Tijana Vlatkovic, Moying Li, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4874-4874
Open Access | Times Cited: 29
ARAP1‐AS1 Overexpression Increases Diffuse Large B Cell Lymphoma Progression by Sponging miR‐508–5p to Activate the EMP1‐PI3K/AKT Pathway
Yamei Chen, Minmin Ren, Yi‐Chun Zhu, et al.
Hematological Oncology (2025) Vol. 43, Iss. 3
Closed Access
Yamei Chen, Minmin Ren, Yi‐Chun Zhu, et al.
Hematological Oncology (2025) Vol. 43, Iss. 3
Closed Access
Non-coding RNAs in radiotherapy resistance: Roles and therapeutic implications in gastrointestinal cancer
Kaiyue Xu, Huimin Guo, Anliang Xia, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114485-114485
Open Access | Times Cited: 7
Kaiyue Xu, Huimin Guo, Anliang Xia, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114485-114485
Open Access | Times Cited: 7
Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
Marcus Bauer, Martina Vetter, Kathrin Stückrath, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 6, pp. 720-731
Open Access | Times Cited: 7
Marcus Bauer, Martina Vetter, Kathrin Stückrath, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 6, pp. 720-731
Open Access | Times Cited: 7
The Landscape and Therapeutic Targeting of BRCA1, BRCA2 and Other DNA Damage Response Genes in Pancreatic Cancer
Ioannis A. Voutsadakis, Antonia Digklia
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 3, pp. 2105-2120
Open Access | Times Cited: 5
Ioannis A. Voutsadakis, Antonia Digklia
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 3, pp. 2105-2120
Open Access | Times Cited: 5
Wee1 epigenetically modulates H2B mono‐ubiquitination at K120 lysine and DNA double‐strand break repair through phosphorylation of H2BY37 ‐dependent manner in small‐cell lung cancer
Xiaoliang Zhao, Xiaohua Wen, Bin Liu
Thoracic Cancer (2023) Vol. 14, Iss. 16, pp. 1420-1429
Open Access | Times Cited: 4
Xiaoliang Zhao, Xiaohua Wen, Bin Liu
Thoracic Cancer (2023) Vol. 14, Iss. 16, pp. 1420-1429
Open Access | Times Cited: 4
Construction of a prognostic model based on memory CD4+ T cell–associated genes for lung adenocarcinoma and its applications in immunotherapy
Yong Li, Xiangli Ye, Huiqin Huang, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 5, pp. 837-852
Open Access | Times Cited: 1
Yong Li, Xiangli Ye, Huiqin Huang, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 5, pp. 837-852
Open Access | Times Cited: 1
An update on small molecule compounds targeting synthetic lethality for cancer therapy
Jiaxiang Luo, Yang Li, Yiwen Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116804-116804
Closed Access | Times Cited: 1
Jiaxiang Luo, Yang Li, Yiwen Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116804-116804
Closed Access | Times Cited: 1
Targeting DNA damage response in pancreatic ductal adenocarcinoma: A review of preclinical and clinical evidence
Fatemeh Moosavi, Bahareh Hassani, Somayeh Nazari, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189185-189185
Closed Access | Times Cited: 1
Fatemeh Moosavi, Bahareh Hassani, Somayeh Nazari, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189185-189185
Closed Access | Times Cited: 1
ZNF131-BACH1 transcriptionally accelerates RAD51-dependent homologous recombination repair and therapy-resistance of non-small-lung cancer cells by preventing their degradation from CUL3
Mingwei Fan, Quanbo Liu, Xiaowen Ma, et al.
Theranostics (2024) Vol. 14, Iss. 18, pp. 7241-7264
Open Access | Times Cited: 1
Mingwei Fan, Quanbo Liu, Xiaowen Ma, et al.
Theranostics (2024) Vol. 14, Iss. 18, pp. 7241-7264
Open Access | Times Cited: 1
Recognition of Glycometabolism-Associated lncRNAs as Prognosis Markers for Bladder Cancer by an Innovative Prediction Model
Dongdong Tang, Yangyang Li, Ying Tang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
Dongdong Tang, Yangyang Li, Ying Tang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma
Yongli Situ, Juying Zhang, Wenyu Liao, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 9
Open Access | Times Cited: 3
Yongli Situ, Juying Zhang, Wenyu Liao, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 9
Open Access | Times Cited: 3
Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma
Ganghua Zhang, Aiyan Chen, Jianing Fang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Ganghua Zhang, Aiyan Chen, Jianing Fang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Evaluating the Therapeutic Effect of Hispidin on Prostate Cancer Cells
Kai-Cheng Chan, Praveenkumar Basavaraj, Jui‐Chen Tsai, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7857-7857
Open Access
Kai-Cheng Chan, Praveenkumar Basavaraj, Jui‐Chen Tsai, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7857-7857
Open Access
miRNAs in radiotherapy resistance of cancer; a comprehensive review
Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Farag M. A. Altalbawy, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1665-1679
Closed Access
Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Farag M. A. Altalbawy, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1665-1679
Closed Access
ZFP57 promotes ovarian cancer progression by transcriptionally regulating BRCA1 and managing G1 checkpoint
Weirong Fan, Rui Xiong, Ziyang Zhou, et al.
Journal of Cancer (2023) Vol. 14, Iss. 11, pp. 2039-2050
Open Access | Times Cited: 1
Weirong Fan, Rui Xiong, Ziyang Zhou, et al.
Journal of Cancer (2023) Vol. 14, Iss. 11, pp. 2039-2050
Open Access | Times Cited: 1
Discovery of potential WEE1 inhibitors via hybrid virtual screening
Tingting Jin, Wei Xu, Roufen Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
Tingting Jin, Wei Xu, Roufen Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
MY11 exerts antitumor effects through activation of the NF-κB/PUMA signaling pathway in breast cancer
Qun Ye, Ziwei Jiang, Ying Xie, et al.
Investigational New Drugs (2022) Vol. 40, Iss. 5, pp. 922-933
Open Access | Times Cited: 1
Qun Ye, Ziwei Jiang, Ying Xie, et al.
Investigational New Drugs (2022) Vol. 40, Iss. 5, pp. 922-933
Open Access | Times Cited: 1
Cancer related-genes enriched in peripheral blood mononuclear cells (PBMCs) of COVID-19 patients. a bioinformatics study
Ehsan Ahmadi, Mostafa Changaei, Alireza Teymouri, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Ehsan Ahmadi, Mostafa Changaei, Alireza Teymouri, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Overexpressed FOXM1 collaborates with MMB to increase WEE1 inhibitor sensitivity in NSCLC
Jian Tan, Jingbo Ma, Weiqiang Zhang, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 6, pp. 3350-3358
Open Access
Jian Tan, Jingbo Ma, Weiqiang Zhang, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 6, pp. 3350-3358
Open Access
